Answers are grounded in this paper and cite their sources.
Background & Aims: Cell death and inflammation cause liver injury during cholestasis. Monocyte infiltration is crucial for the inflammatory response in tissues and organs. Thus, to study the role of monocytes in cholestatic liver disease, we used single-cell RNA sequencing (scRNA-seq) to analyze liver non-parenchymal cells (NPCs) from patients with obstructive cholestasis (OC). Methods: monocytes were isolated by flow cytometry for analysis of tumor necrosis factor-alpha (TNFα) and factor-related apoptosis ligand (FASL) expression. Conclusion: monocytes promote hepatocyte necroptosis and exacerbate cholestatic liver injury. Thus, targeting their chemotaxis represents a promising therapeutic strategy against cholestasis. Impact and implications: monocyte infiltration by upregulating CCL2 and CCL3 via JNK/c-Jun signaling. These findings highlight the therapeutic potential of modulating monocyte infiltration or necroptosis pathways to alleviate disease progression, offering novel strategies for treating OC and related liver pathologies.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: